The Essential Role of 17-Octadecynoic Acid in the Pathogenesis of Periapical Abscesses.


Journal

Journal of endodontics
ISSN: 1878-3554
Titre abrégé: J Endod
Pays: United States
ID NLM: 7511484

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 08 10 2022
revised: 27 11 2022
accepted: 02 12 2022
pubmed: 18 12 2022
medline: 31 1 2023
entrez: 17 12 2022
Statut: ppublish

Résumé

Periapical abscesses are 1 of the most frequent pathologic lesions in the alveolar bone. Recently, we have identified 17-octadecynoic acid (17-ODYA) as the highest unique metabolite in periapical abscesses. Therefore, the aim of this study was to investigate the immunologic and pathophysiological roles of this metabolite in the initiation and development of periapical abscesses. Periodontal ligament fibroblasts and peripheral blood mononuclear cells were treated with 17-ODYA. Gene expression analysis and interleukin (IL)-8 release were determined using quantitative real-time polymerase chain reaction and enzyme-linked immunosorbent assay. Macrophage polarization and cytokine release were also determined using flow cytometry and Luminex bioassay (R&D Systems, Minneapolis, MN), respectively. In periodontal ligament fibroblasts, 17-ODYA caused significant (P < .0001) up-regulation of IL-1α, IL-1β, IL-6, matrix metalloproteinase-1, and monocyte chemoattractant protein-1 at 10 μmol/L after 6 days of treatment and up-regulation of platelet-derived growth factor alpha and vascular endothelial growth factor alpha at all tested concentrations after 2 days of treatment. In peripheral blood mononuclear cells, 17-ODYA significantly increased the expression of IL-1α, IL-1β, IL-6, matrix metalloproteinase-1, and monocyte chemoattractant protein-1 at 10 μmol/L (P < .0001) and vascular endothelial growth factor alpha and platelet-derived growth factor alpha at 1 μmol/L 17-ODYA (P < .0001). 17-ODYA polarized macrophages toward a proinflammatory phenotype (M1) and suppressed the release of pro- and anti-inflammatory cytokines. 17-ODYA significantly enhanced the release of IL-8. This study was the first to identify the pathologic role of 17-ODYA in the development of periapical abscesses. The results of this study are important in shedding light on the pathogenesis of periapical abscesses in relation to microbial metabolites.

Identifiants

pubmed: 36528175
pii: S0099-2399(22)00823-8
doi: 10.1016/j.joen.2022.12.002
pii:
doi:

Substances chimiques

Chemokine CCL2 0
17-octadecynoic acid 34450-18-5
Matrix Metalloproteinase 1 EC 3.4.24.7
Interleukin-6 0
Vascular Endothelial Growth Factor A 0
Platelet-Derived Growth Factor 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article

Langues

eng

Pagination

169-177.e3

Informations de copyright

Copyright © 2022 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.

Auteurs

Alaa M Altaie (AM)

Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates; Department of Oral and Craniofacial Health Sciences, College of Dental Medicine, University of Sharjah, Sharjah, United Arab Emirates; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.

Mohammad G Mohammad (MG)

Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates; Department of Medical Laboratory Sciences, College of Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.

Mohamed I Madkour (MI)

Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates; Department of Medical Laboratory Sciences, College of Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.

Sarra B Shakartalla (SB)

Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.

Manju Nidagodu Jayakumar (MN)

Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.

Aghila Rani K G (AR)

Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.

Rabih Halwani (R)

Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.

A R Samsudin (AR)

Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates; Department of Oral and Craniofacial Health Sciences, College of Dental Medicine, University of Sharjah, Sharjah, United Arab Emirates.

Rifat A Hamoudi (RA)

Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Division of Surgery and Interventional Science, University College London, London, United Kingdom. Electronic address: rhamoudi@sharjah.ac.ae.

Sameh S M Soliman (SSM)

Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates; Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates. Electronic address: ssoliman@sharjah.ac.ae.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH